Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Copper
Drug ID BADD_D00529
Description Copper is a transition metal and a trace element in the body. It is important to the function of many enzymes including cytochrome c oxidase, monoamine oxidase and superoxide dismutase [FDA Label]. Copper is commonly used in contraceptive intrauterine devices (IUD) [L801].
Indications and Usage For use in the supplementation of total parenteral nutrition and in contraception with intrauterine devices [FDA Label] [L801].
Marketing Status approved; investigational
ATC Code Not Available
DrugBank ID DB09130
KEGG ID Not Available
MeSH ID D003300
PubChem ID 23978
TTD Drug ID D01WMJ
NDC Product Code 68428-349; 82815-0001; 62106-5020; 51285-204; 0220-1623; 0220-1635; 59365-5128; 68428-140; 64117-958; 0220-1636
UNII 789U1901C5
Synonyms Copper | Copper-63 | Copper 63
Chemical Information
Molecular Formula Cu
CAS Registry Number 7440-50-8
SMILES [Cu]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal adhesions07.07.03.001; 12.02.03.006--
Abdominal pain07.01.05.002-
Abdominal pain lower07.01.05.010--
Abdominal tenderness07.01.05.004--
Abortion18.01.01.001--
Abortion incomplete18.01.01.003--
Abortion infected11.01.10.015; 18.01.03.002---
Abortion missed18.01.01.002--
Abortion spontaneous18.01.04.001--
Acne cystic23.02.01.005--
Amenorrhoea05.05.01.002; 21.01.02.001-
Anaemia01.03.02.001--
Anhedonia19.15.02.007--
Anxiety19.06.02.002-
Back pain15.03.04.005--
Bartholin's cyst16.04.04.003; 21.08.03.001--
Benign hydatidiform mole16.04.01.002; 18.05.03.001; 21.07.02.006--
Breast discharge21.05.05.001--
Breast enlargement21.05.04.001--
Breast mass21.05.04.002--
Breast tenderness21.05.05.004--
Calculus bladder20.04.03.001--
Cervical discharge21.06.01.001--
Cervical dysplasia21.06.01.002--
Cervical polyp16.04.05.001; 21.06.02.004--
Cervix disorder21.06.01.003--
Cyst08.03.05.001; 16.02.02.002--
Dermatitis allergic10.01.03.014; 23.03.04.003---
Dermatitis atopic10.01.04.004; 23.03.04.016---
Device expulsion27.01.01.002---
The 1th Page    1 2 3 4 5    Next   Last    Total 6 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene